SC 13G: CEMTREX INC
Ticker: CETXP · Form: SC 13G · Filed: Oct 10, 2024 · CIK: 1435064
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by CEMTREX INC.
Risk Assessment
Risk Level: low
Filing Stats: 836 words · 3 min read · ~3 pages · Grade level 8.6 · Accepted 2024-10-10 14:37:55
Filing Documents
- tm2425525d3_sc13g.htm (SC 13G) — 52KB
- 0001104659-24-107675.txt ( ) — 53KB
(a). Name of Issuer
Item 1(a). Name of Issuer: Cemtrex Inc.
(b).Address
Item 1(b).Address of Issuer’s Principal Executive Offices: 276 Greenpoint Ave. Bld 8 Suite 208 BROOKLYN, NY, 11222 United States
(a).Name
Item 2(a).Name of Person Filing: Forsakringsaktiebolaget Avanza Pension
(b). Address of Principal Business Office or, if None, Residence
Item 2(b). Address of Principal Business Office or, if None, Residence: Box 1399 STOCKHOLM, 11139 SWEDEN
(c). Citizenship
Item 2(c). Citizenship: Forsakringsaktiebolaget Avanza Pension is a company organized under the laws of Sweden
(d). Title of Class of Securities
Item 2(d). Title of Class of Securities: Common Stock
(e). CUSIP Number:15130G808
Item 2(e). CUSIP Number:15130G808
If
Item 3.If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o) (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c) (c) Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c) (d) Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) (e) Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E) (f) Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F) (g) Parent Holding Company or control person in accordance with §240.13d-1(b)(1)(ii)(G) (h) Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) Church plan that is excluded from the definition of an investment company under §3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) CUSIP No.: 15130G808 SCHEDULE 13G Page 4of 6 Pages (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J) (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K)
Ownership
Item 4. Ownership. (a) Amount beneficially owned:56,051 (b) Percent of class: 19,29% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote:56,051 (ii) Shared power to vote or to direct the vote:None (iii) Sole power to dispose or to direct the disposition of:None (iv) Shared power to dispose or to direct the disposition of: 56,051 Number and Percentage of Shares Beneficially Owned Date 19,29% / 56,051 October 10, 2024
Ownership of Five Percent or Less of a Class
Item 5. Ownership of Five Percent or Less of a Class. Not applicable
Ownership of More than Five Percent on Behalf of Another Person
Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. CUSIP No.: 15130G808 SCHEDULE 13G Page 5of 6 Pages Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable
Identification and Classification of Members of the Group
Item 8. Identification and Classification of Members of the Group. Not applicable
Notice of Dissolution of Group
Item 9. Notice of Dissolution of Group. Not applicable CUSIP No.: 15130G808 SCHEDULE 13G Page 6of 6 Pages
Certification
Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to a Swedish insurance company is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution. I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D. SIGNATURE After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct. October 10, 2024 /s/ Marie Karlsfeldt Marie Karlsfeldt / Middle Office Name/Title